俄罗斯国际多中心药物临床试验登记册
学习清单: 学习 1: 标题: A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: 癌症|白内障|骨矿物质密度低|骨质减少|骨质疏松症|Prostate Cancer Interventions: 生物: 狄诺塞麦|生物: Placebo URL: http://ClinicalTrials.gov/show/NCT00925600 Study 2: 标题: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Intra-Abdominal Infection Interventions: 药品: 莫西沙星 (艾维乐克斯, BAY12-8039)|药品: 厄他培南, Amoxicillin/clavulanate URL: http://ClinicalTrials.gov/show/NCT01069900 Study 3: 标题: A Study of LY2140023 in Patients With Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: 药品: LY2140023|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01307800 Study 4: 标题: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thrombosis Interventions: 药品: 依诺肝素|药品: 华法林|药品: 阿哌沙班安慰剂|药品: 依诺肝素安慰剂|药品: 华法林安慰剂|药品: apixaban URL: http://ClinicalTrials.gov/show/NCT00643201 Study 5: 标题: 逻辑 - ErbB2 拉帕替尼优化研究 (HER2) 胃癌阳性: 全球第三期, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Recruitment: Recruiting Study Results: No Results Available Conditions: 或因局部晚期转移而无法切除的胃食管连接部腺癌, 或局部复发性疾病。|厄尔巴B2 (HER2) 放大胃|肿瘤, 胃肠道|Esophageal Interventions: 药品: 拉帕替尼|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00680901 Study 6: 标题: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: 晚期乳腺癌|Breast Cancer Interventions: 药品: 来那替尼|药品: 拉帕替尼|药品: Capecitabine URL: http://ClinicalTrials.gov/show/NCT00777101 Study 7: 标题: 开放标签, 随机化, 评估疗效的多中心 IIIb 期研究, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical or Urgent Invasive Procedure Recruitment: Recruiting Study Results: No Results Available Conditions: Reversal of Coagulopathy Interventions: 生物: Beriplex® P/N|生物: Fresh frozen plasma URL: http://ClinicalTrials.gov/show/NCT00803101 Study 8: 标题: Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: 药品: 干扰素b 1a|药品: DAC HYP URL: http://ClinicalTrials.gov/show/NCT01064401 Study 9: 标题: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Renal Cell Carcinoma Interventions: 药品: 舒尼替尼|生物: IMA901 加上 GM-CSF|药品: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01265901 Study 10: 标题: A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: 网址: http://ClinicalTrials.gov/show/NCT01394601 Study 11: 标题: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Recruitment: Recruiting Study Results: No Results Available Conditions: 心血管疾病|心脏病|心脏衰竭, Congestive Interventions: 药品: 醛固酮拮抗剂 (螺内酯)|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00094302 Study 12: 标题: A阶段 3 Brentuximab Vedotin 的研究 (SGN-35) 干细胞移植后残留霍奇金淋巴瘤高风险患者 (以太审判) 招聘: Recruiting Study Results: No Results Available Conditions: 疾病, Hodgkin Interventions: 药品: 布伦妥昔单抗维多汀|药品: placebo URL: http://ClinicalTrials.gov/show/NCT01100502 Study 13: 标题: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: 癫痫发作|癫痫|Partial-Onset Seizures Interventions: 药品: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01227902 Study 14: 标题: A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: 药品: LY2127399|药品: 安慰剂每 2 周|药品: 安慰剂每 4 weeks URL: http://ClinicalTrials.gov/show/NCT01198002 Study 15: 标题: 恩尿嘧啶的研究 + 5-氟尿嘧啶 (5-福) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer Interventions: 药品: 恩尿嘧啶|药品: 5-氟尿嘧啶|药品: 亚叶酸|药品: Capecitabine URL: http://ClinicalTrials.gov/show/NCT01231802 Study 16: 标题: A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Recruitment: Recruiting Study Results: No Results Available Conditions: 瘤|Pain Interventions: 药品: CG5503 IS|药品: 安慰剂匹配 CG5503|药品: 硫酸吗啡 CR|药品: Placebo to match Morphine Sulphate CR URL: http://ClinicalTrials.gov/show/NCT00472303 Study 17: 标题: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: 药品: ATN-103|药品: ATN-103 URL: http://ClinicalTrials.gov/show/NCT01063803 Study 18: 标题: 比较皮下注射与静脉注射 MabThera 的研究 (利妥昔单抗) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia Recruitment: Recruiting Study Results: No Results Available Conditions: 淋巴细胞白血病, Chronic Interventions: 药品: 利妥昔单抗 [美罗华]|药品: 利妥昔单抗 [美罗华]|药品: 利妥昔单抗 [美罗华]|药品: 氟达拉滨|药品: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01292603 Study 19: 标题: A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection Recruitment: Recruiting Study Results: No Results Available Conditions: 慢性乙型肝炎病毒, Pediatric Interventions: 药品: 恩替卡韦|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01079806 Study 20: 标题: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Recruitment: Recruiting Study Results: No Results Available Conditions: 脱发|Androgenetic Alopecia Interventions: 药品: 1毫克非那雄胺活性|药品: 0.02度他雄胺毫克|药品: 0.1度他雄胺毫克|药品: 0.5度他雄胺毫克|药品: 非那雄胺安慰剂|药品: Dutasteride placebo URL: http://ClinicalTrials.gov/show/NCT01231607 Study 21: 标题: Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Recruitment: Recruiting Study Results: No Results Available Conditions: 心房颤动|心律失常|预防中风|Mortality Interventions: 设备: 左心房消融术|药品: Rate or Rhythm Control Therapy URL: http://ClinicalTrials.gov/show/NCT00911508 Study 22: 标题: 阿格列汀对不同类型受试者的心血管结局研究 2 Diabetes and Acute Coronary Syndrome Recruitment: Recruiting Study Results: No Results Available Conditions: 糖尿病, 类型 2|Acute Coronary Syndrome Interventions: 药品: 阿格列汀|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00968708 Study 23: 标题: 噻托溴铵的评价 2.5 和 5 与安慰剂和沙美特罗 HydroFluoroAlkane 相比，通过 Respimat® 吸入器每天输送一次 Mcg (氢氟酸) 定量吸入器 (MDI) (50 每日麦格两次) in Patient With Moderate Persistent Asthma I Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: 药品: 安慰剂|药品: 安慰剂|药品: 安慰剂|药品: 安慰剂|药品: 安慰剂|药品: 50 微克沙美特罗 HFA MDI|药品: 5 微克噻托溴铵 Respimat®|药品: 2.5 mcg tiotropium Respimat® URL: http://ClinicalTrials.gov/show/NCT01172808 Study 24: 标题: Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatocellular Carcinoma Interventions: 药品: 索拉非尼|生物: mapatumumab URL: http://ClinicalTrials.gov/show/NCT01258608 Study 25: 标题: 来曲唑伴或不伴PD的研究 0332991 For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: 药品: PD 0332991|药品: 来曲唑|药品: letrozole URL: http://ClinicalTrials.gov/show/NCT00721409 Study 26: 标题: Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin Recruitment: Recruiting Study Results: No Results Available Conditions: 肺癌 - Non Small Cell Interventions: 药品: 伊匹木单抗|药品: 安慰剂|药品: 紫杉醇|药品: Carboplatin URL: http://ClinicalTrials.gov/show/NCT01285609 Study 27: 标题: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Alzheimer Disease Interventions: 药品: 巴品珠单抗|药品: 巴品珠单抗|药品: placebo URL: http://ClinicalTrials.gov/show/NCT00667810 Study 28: 标题: 有效性研究 & 来那度胺与苯丁酸氮芥作为老年 B 细胞 CLL 患者一线治疗的安全性 (起源审判) 招聘: Recruiting Study Results: No Results Available Conditions: B 细胞慢性淋巴细胞白血病 (慢性淋巴细胞白血病) 干预措施: 药品: 来那度胺|药品: Chlorambucil URL: http://ClinicalTrials.gov/show/NCT00910910 Study 29: 标题: 美罗华研究 (利妥昔单抗) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status Recruitment: Recruiting Study Results: No Results Available Conditions: 淋巴细胞白血病, Chronic Interventions: 药品: 利妥昔单抗 [美罗华]|药品: 氟达拉滨|药品: cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01271010 Study 30: 标题: 比较芳香酶抑制剂与拉帕替尼联合使用的安全性和有效性的研究, 曲妥珠单抗或两者用于治疗激素受体阳性, HER2+ Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: 肿瘤, Breast Interventions: 药品: 拉帕替尼|药品: 曲妥珠单抗|药品: 芳香酶抑制剂|药品: lapatinib URL: http://ClinicalTrials.gov/show/NCT01160211 Study 31: 标题: 长期的, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee Recruitment: Recruiting Study Results: No Results Available Conditions: Osteoarthritis Interventions: 药品: SD-6010|药品: SD-6010|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00565812 Study 32: 标题: 商业智能研究 54903 (吸入皮质类固醇) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Asthma Interventions: 药品: 安慰剂匹配 Respimat|药品: 安慰剂匹配 Respimat|药品: 双 54903 医学博士|药品: 双 54903 HD URL: http://ClinicalTrials.gov/show/NCT01458912 Study 33: 标题: Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure Recruitment: Recruiting Study Results: No Results Available Conditions: Heart Failure Interventions: 药品: 安慰剂|药品: Omecamtiv mecarbil URL: http://ClinicalTrials.gov/show/NCT01300013 Study 34: 标题: Study of Immunotherapy to Treat Advanced Prostate Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: 药品: 伊匹木单抗|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00861614 Study 35: 标题: 阶段 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Non-small Cell Lung Cancer Interventions: 药品: 他沃西普(BNP7787) 与顺铂和多西紫杉醇或紫杉醇联合使用|药品: Placebo in combination with cisplatin and docetaxel or paclitaxel URL: http://ClinicalTrials.gov/show/NCT00966914 Study 36: 标题: 一功效, 安全, 卡格列净在 1 型患者中的耐受性研究 2 Diabetes Mellitus Who Have Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: 糖尿病, 类型 2|Renal Insufficiency Interventions: 药品: 卡格列净 100 毫克|药品: 卡格列净 300 毫克|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01064414 Study 37: 标题: ACT-293987 in Pulmonary Arterial Hypertension Recruitment: Recruiting Study Results: No Results Available Conditions: Pulmonary Arterial Hypertension Interventions: 药品: ACT-293987|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01106014 Study 38: 标题: RoActemra/Actemra 皮下注射与静脉注射比较的研究 (托珠单抗) in Patients With Moderate to Severe Active Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: 药品: 托珠单抗 [罗阿克泰姆拉/Actemra]|药品: 托珠单抗 [罗阿克泰姆拉/Actemra]|药品: 安慰剂|药品: 安慰剂|药品: 缓解疾病的抗风湿药物 (DMARDs) 网址: http://ClinicalTrials.gov/show/NCT01194414 Study 39: 标题: 福斯塔替尼治疗类风湿关节炎的长期安全性和有效性评价 (RA) 招聘: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: 药品: 福斯塔替尼|药品: 福斯塔替尼|药品: Fostamatinib URL: http://ClinicalTrials.gov/show/NCT01242514 Study 40: 标题: RED-HF™ 试用版 - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial Recruitment: Recruiting Study Results: No Results Available Conditions: 心脏衰竭|贫血|心血管疾病|心室功能障碍|Congestive Heart Failure Interventions: 药品: 达贝泊汀阿尔法|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00358215 Study 41: 标题: AVAPERL1 研究: 阿瓦斯丁的研究 (贝伐珠单抗) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: 药品: 贝伐珠单抗 [我发现]|药品: 培美曲塞|药品: cisplatin URL: http://ClinicalTrials.gov/show/NCT00961415 Study 42: 标题: ACT-129968 在部分控制的哮喘成年患者中的研究. 招聘: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: 药品: ACT-129968|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01225315 Study 43: 标题: 伊沙匹隆作为局部晚期二线治疗的研究, Recurrent or Metastatic Endometrial Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancer Interventions: 药品: 沙贝匹隆|药品: 阿霉素|药品: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT00883116 Study 44: 标题: 阿西替尼 (股份公司-013736) For the Treatment of Metastatic Renal Cell Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Neoplasms Interventions: 药品: 阿西替尼 (股份公司-013736)|药品: Sorafenib URL: http://ClinicalTrials.gov/show/NCT00920816 Study 45: 标题: GSK1349572 与拉替拉韦的研究 (劳尔) 研究人员选择具有抗逆转录病毒经验的背景治疗方案, Integrase Inhibitor-Naive Adults Recruitment: Recruiting Study Results: No Results Available Conditions: 感染, Human Immunodeficiency Virus Interventions: 药品: GSK1349572|药品: 拉替拉韦|药品: GSK1349572 安慰剂|药品: Raltegravir Placebo URL: http://ClinicalTrials.gov/show/NCT01231516 Study 46: 标题: BI 的滚动研究 201335 与聚乙二醇化干扰素-α 和利巴韦林联合治疗经历过的基因型 1 Hepatitis C Infected Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: 药品: 聚乙二醇干扰素/RBV|药品: 双 201335 网址: http://ClinicalTrials.gov/show/NCT01330316 Study 47: 标题: Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: 多发性硬化症|Relapsing-remitting Interventions: 药品: AIN457|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01051817 Study 48: 标题: Xolair 的功效和安全性研究 (奥马珠单抗) 慢性特发性荨麻疹患者 (中央情报局)/慢性自发性荨麻疹 (科罗拉多州立大学) 尽管接受抗组胺药治疗但仍有症状的人 (H1) 招聘: Recruiting Study Results: No Results Available Conditions: Chronic Idiopathic Urticaria Interventions: 药品: 奥马珠单抗|药品: placebo URL: http://ClinicalTrials.gov/show/NCT01287117 Study 49: 标题: 艾沙康唑 (巴尔8557) in the Treatment of Candidemia and Other Invasive Candida Infections Recruitment: Recruiting Study Results: No Results Available Conditions: 真菌病|念珠菌病, 侵入性|Candidemia Interventions: 药品: 艾沙康唑|药品: 卡泊芬净|药品: Voriconazole URL: http://ClinicalTrials.gov/show/NCT00413218 Study 50: 标题: BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: 卵巢肿瘤|Peritoneal Neoplasms Interventions: 药品: BIBF 1120|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01015118 Study 51: 标题: 免疫原性和药代动力学 (PK) DAC HYP预充式注射器治疗复发缓解型多发性硬化症的研究 (均方根值) 招聘: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: 生物: Daclizumab High Yield Process prefilled syringe URL: http://ClinicalTrials.gov/show/NCT01462318 Study 52: 标题: Study in Adolescents With Schizophrenia or Bipolar Disorder Recruitment: Recruiting Study Results: No Results Available Conditions: I型双相情感障碍|Schizophrenia Interventions: 药品: 奥氮平|行为方面: 标准行为体重干预|行为方面: Intense behavioral weight intervention URL: http://ClinicalTrials.gov/show/NCT00982020 Study 53: 标题: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation Recruitment: Recruiting Study Results: No Results Available Conditions: Coronary Artery Disease Interventions: 药品: RVX000222|药品: Placebo RVX000222 URL: http://ClinicalTrials.gov/show/NCT01067820 Study 54: 标题: RO4917838 在精神分裂症症状控制不佳的患者中的研究 (NN25307) 招聘: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: 药品: RO4917838|药品: RO4917838|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01235520 Study 55: 标题: Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy Recruitment: Recruiting Study Results: No Results Available Conditions: 甲状旁腺功能亢进症, Primary Interventions: 药品: 盐酸西那卡塞|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00975221 Study 56: 标题: 类风湿性关节炎患者福斯塔替尼两种给药方案与安慰剂相比的有效性评估 (RA) 正在服用甲氨蝶呤但没有反应的人. 招聘: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: 药品: 福斯塔替尼|药品: 福斯塔替尼|药品: 安慰剂, fostamatinib URL: http://ClinicalTrials.gov/show/NCT01197521 Study 57: 标题: 瑞替加滨速释剂的长期安全性研究 (和) 作为治疗成人部分性癫痫发作的辅助疗法 (销售点). 招聘: Recruiting Study Results: No Results Available Conditions: 癫痫发作|癫痫|Partial-Onset Seizures Interventions: 药品: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01336621 Study 58: 标题: ErbB2 中拉帕替尼加卡培他滨与曲妥珠单抗加卡培他滨的比较 (HER2) 阳性转移性乳腺癌. 招聘: Recruiting Study Results: No Results Available Conditions: 转移性乳腺癌|转移, Brain Interventions: 药品: 卡培他滨|药品: 拉帕替尼|药品: trastuzumab URL: http://ClinicalTrials.gov/show/NCT00820222 Study 59: 标题: STREAM-策略性再灌注 (替奈普酶和抗血栓治疗) Early After Myocardial Infarction Recruitment: Recruiting Study Results: No Results Available Conditions: Myocardial Infarction Interventions: 药品: 替奈普酶|药品: 依诺肝素|药品: 氯吡格雷|程序: 导管插入术|程序: primary PCI URL: http://ClinicalTrials.gov/show/NCT00623623 Study 60: 标题: Ocrelizumab 与干扰素 Beta-1a 的比较研究 (雷比夫) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: 多发性硬化症, Relapsing-Remitting Interventions: 药品: 奥瑞珠单抗|药品: 雷比夫|药品: 奥瑞珠单抗安慰剂|药品: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01247324 Study 61: 标题: 卡罗莱纳州: 利格列汀与格列美脲治疗 2 型患者的心血管结局研究 2 Diabetes Recruitment: Recruiting Study Results: No Results Available Conditions: 糖尿病, 类型 2 干预措施: 药品: 利格列汀|药品: glimepiride URL: http://ClinicalTrials.gov/show/NCT01243424 Study 62: 标题: PANORAMA Observational Study Recruitment: Recruiting Study Results: No Results Available Conditions: 心律失常|心脏起搏器, 人造的|除颤器, Implantable Interventions: 设备: 心脏起搏器, 除颤器, pacemaker lead URL: http://ClinicalTrials.gov/show/NCT00382525 Study 63: 标题: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: 肿瘤抗原阳性非小细胞肺癌|肺癌, Non-Small Cell Interventions: 生物: GSK1572932A 抗原特异性癌症免疫治疗|生物: Placebo Control URL: http://ClinicalTrials.gov/show/NCT00480025 Study 64: 标题: 每周一次 NeoRecormon 的生活质量和治疗反应研究 (β依泊汀) 实体瘤和淋巴恶性肿瘤贫血患者的治疗. 招聘: Recruiting Study Results: No Results Available Conditions: Anemia Interventions: 药品: β-促红细胞生成素 [新雷科蒙]|药品: β-促红细胞生成素 [新雷科蒙] 网址: http://ClinicalTrials.gov/show/NCT00776425 Study 65: 标题: 长期 Innohep® 治疗与维生素 K 拮抗剂的比较 (华法林) 用于治疗静脉血栓栓塞 (静脉血栓栓塞症) in Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thromboembolism Interventions: 药品: 华法林|药品: Innohep® URL: http://ClinicalTrials.gov/show/NCT01130025 Study 66: 标题: Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: 药品: HIV therapy URL: http://ClinicalTrials.gov/show/NCT01275625 Study 67: 标题: 勒克斯-乳房 2; HER2 中的阿法替尼 (人表皮生长因子受体)-Treatment Failures Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Neoplasms Interventions: 药品: 阿法替尼 40 毫克，每日一次 (的)|药品: 长春瑞滨 25 毫克/平方米每周|药品: 紫杉醇 80 mg/m2 weekly URL: http://ClinicalTrials.gov/show/NCT01271725 Study 68: 标题: Onartuzumab 的研究 (甲硫氨酸单克隆抗体) 与特罗凯联合使用 (厄洛替尼) 在接受晚期或转移性疾病化疗的 Met 诊断阳性非小细胞肺癌患者中 (气象肺) 招聘: Not yet recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: 药品: 奥那珠单抗 [甲硫氨酸单克隆抗体]|药品: 厄洛替尼 [特罗凯]|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01456325 Study 69: 标题: 多西紫杉醇的 III 期研究 + Ramucirumab or Placebo in Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: 生物: 雷莫芦单抗 (IMC-1121B)|药品: 多西紫杉醇|其他: placebo URL: http://ClinicalTrials.gov/show/NCT00703326 Study 70: 标题: ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing-remitting Multiple Sclerosis Interventions: 药品: ACT-128800|药品: ACT-128800|药品: ACT-128800 URL: http://ClinicalTrials.gov/show/NCT01093326 Study 71: 标题: 双盲, 安慰剂对照, 2-加兰他敏用于治疗轻至中度阿尔茨海默病患者的年研究. 招聘: Recruiting Study Results: No Results Available Conditions: 阿尔茨海默病|失智, Alzheimer Type Interventions: 药品: 加兰他敏|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00679627 Study 72: 标题: 乌司奴单抗治疗青少年银屑病患者的安全性和有效性研究 (卡迪姆斯) 招聘: Recruiting Study Results: No Results Available Conditions: Psoriasis Interventions: 生物: 优特克单抗/安慰剂|生物: 优特克单抗/安慰剂|生物: ustekinumab/placebo URL: http://ClinicalTrials.gov/show/NCT01090427 Study 73: 标题: PEARL Schizophrenia Maintenance Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: 药品: 鲁拉西酮|药品: Matching Placebo URL: http://ClinicalTrials.gov/show/NCT01435928 Study 74: 标题: Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Recruitment: Recruiting Study Results: No Results Available Conditions: Preterm Birth Interventions: 药品: 己酸羟孕酮注射液, 250毫克/毫升|药品: Vehicle URL: http://ClinicalTrials.gov/show/NCT01004029 Study 75: 标题: 阿格列扎类型研究 2 Diabetes Patients With Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: 糖尿病, 类型 2 干预措施: 药品: 阿格列扎|药品: pioglitazone URL: http://ClinicalTrials.gov/show/NCT01043029 Study 76: 标题: 罗氟司特治疗慢性阻塞性肺疾病 (慢性阻塞性肺病) 使用长效 β2 激动剂固定组合治疗的患者 (二) 和吸入糖皮质激素 (工业控制系统) 招聘: Recruiting Study Results: No Results Available Conditions: Chronic Obstructive Pulmonary Disease Interventions: 药品: 来自罗氟司特|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01329029 Study 77: 标题: 苯达莫司汀与苯达莫司汀+RO5072759比较的有效性和安全性研究 (GA101) 利妥昔单抗难治性患者, Indolent Non-Hodgkin's Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Hodgkin's Lymphoma Interventions: 药品: 我们必须有|药品: RO5072759 URL: http://ClinicalTrials.gov/show/NCT01059630 Study 78: 标题: 功效和安全性 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: 药品: 2.5 微克噻托溴铵能倍马|药品: 安慰剂 能倍乐|药品: 2.5 mcg tiotropium Respimat URL: http://ClinicalTrials.gov/show/NCT01257230 Study 79: 标题: TMC125IFD3002 - 小提琴研究: 评估依曲韦林耐受性, PharmacOkinetics With Other AntiretroviraLs In TreatmeNt Experienced Patients Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: 药品: etravirine URL: http://ClinicalTrials.gov/show/NCT01422330 Study 80: 标题: Study of Paclitaxel in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: 上皮性卵巢癌|原发性腹膜癌|Fallopian Tube Cancer Interventions: 药品: 帕可卡®|药品: Taxol® URL: http://ClinicalTrials.gov/show/NCT00989131 Study 81: 标题: 阿瓦斯汀添加的研究 (贝伐珠单抗) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Cancer Interventions: 药品: 贝伐珠单抗 [我发现]|药品: 卡铂|药品: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT01239732 Study 82: 标题: Asthma in Children Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: 网址: http://ClinicalTrials.gov/show/NCT01286532 Study 83: 标题: 美罗华研究 (利妥昔单抗) 对单一抗 TNF 抑制剂反应不足的类风湿关节炎患者. 招聘: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: 药品: 利妥昔单抗 [美罗华/利妥昔单抗]|药品: Methotrexate URL: http://ClinicalTrials.gov/show/NCT00576433 Study 84: 标题: Ocrelizumab 与干扰素 Beta-1a 的比较研究 (雷比夫) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: 多发性硬化症, Relapsing-Remitting Interventions: 药品: 奥瑞珠单抗|药品: 雷比夫|药品: 奥瑞珠单抗安慰剂|药品: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01412333 Study 85: 标题: 卡铂/紫杉醇联合 ABT-869 在晚期或转移性非小细胞肺癌受试者中的研究 (非小细胞肺癌) 招聘: Recruiting Study Results: No Results Available Conditions: Advanced or Metastatic Non-Small Cell Lung Cancer Interventions: 药品: ABT-869|药品: ABT-869 的安慰剂|药品: ABT-869 URL: http://ClinicalTrials.gov/show/NCT00716534 Study 86: 标题: Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: 网址: http://ClinicalTrials.gov/show/NCT01320735 Study 87: 标题: CNTO的安全性和有效性研究 328 in Combination With Best Supportive Care Compared to Best Supportive Care in Patients With Multicentric Castleman's Disease Recruitment: Recruiting Study Results: No Results Available Conditions: Castleman's Disease Interventions: 其他: 安慰剂|药品: 中国科技组织 328 网址: http://ClinicalTrials.gov/show/NCT01024036 Study 88: 标题: SAR153191评估(雷根88) on Top of Methotrexate in Rheumatoid Arthritis Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: 药品: SAR153191 (雷根88)|药品: placebo URL: http://ClinicalTrials.gov/show/NCT01061736 Study 89: 标题: A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Transplantation Interventions: 药品: 阿德瓦格拉夫|药品: 吗替麦考酚酯|药品: 模拟|药品: Corticosteroids URL: http://ClinicalTrials.gov/show/NCT01304836 Study 90: 标题: 利妥昔单抗联合用药的研究, 环磷酰胺, 阿霉素, 维尔卡德, 和泼尼松或利妥昔单抗, 环磷酰胺, 阿霉素, 长春新碱, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Mantle Cell Lymphoma Interventions: 药品: 利妥昔单抗, 环磷酰胺, 阿霉素, 维尔卡德, 和泼尼松|药品: 利妥昔单抗, 环磷酰胺, 阿霉素, Vincristine and Prednisone URL: http://ClinicalTrials.gov/show/NCT00722137 Study 91: 标题: 双盲, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects Recruitment: Recruiting Study Results: No Results Available Conditions: DLBCL Interventions: 生物: TL011|生物: Rituximab URL: http://ClinicalTrials.gov/show/NCT01205737 Study 92: 标题: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: 药品: 索拉非尼(多吉美, BAY43-9006) / 卡培他滨|药品: 安慰剂 / Capecitabine URL: http://ClinicalTrials.gov/show/NCT01234337 Study 93: 标题: RoActemra/Actemra的研究 (托珠单抗) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Recruitment: Recruiting Study Results: No Results Available Conditions: 心血管疾病, Rheumatoid Arthritis Interventions: 药品: 托珠单抗 [罗阿克泰姆拉/Actemra]|药品: etanercept URL: http://ClinicalTrials.gov/show/NCT01331837 Study 94: 标题: Pregabalin Versus Levetiracetam In Partial Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Partial Seizures Interventions: 药品: 普瑞巴林|药品: levetiracetam URL: http://ClinicalTrials.gov/show/NCT00537238 Study 95: 标题: 匹马范色林的安全性和耐受性研究 (ACP-103) in Patients With Parkinson's Disease Psychosis Recruitment: Recruiting Study Results: No Results Available Conditions: Parkinson's Disease Psychosis Interventions: 药品: 酒石酸匹莫范色林 (ACP-103) 网址: http://ClinicalTrials.gov/show/NCT00550238 Study 96: 标题: 艾塞那肽降低心血管事件试验研究 (埃克斯塞尔): 一项评估 A 型患者每周一次艾塞那肽治疗后心血管结果的试验 2 Diabetes Mellitus Recruitment: Recruiting Study Results: No Results Available Conditions: 类型 2 Diabetes Mellitus Interventions: 药品: 艾塞那肽每周一次|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01144338 Study 97: 标题: A Study of LY2127399 in Patients With Systemic Lupus Erythematosus Recruitment: Recruiting Study Results: No Results Available Conditions: 系统性红斑狼疮|结缔组织病|Autoimmune Disease Interventions: 药品: LY2127399|药品: 安慰剂每 2 周|药品: 安慰剂每 4 weeks URL: http://ClinicalTrials.gov/show/NCT01205438 Study 98: 标题: Study of FP-1039 in Subjects With Endometrial Cancers Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancers With FGFR2 Mutations Interventions: 药品: FP-1039 URL: http://ClinicalTrials.gov/show/NCT01244438 Study 99: 标题: TMC435HPC3007 - TMC435基因型III期试验 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: 药品: TMC435|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT01281839 Study 100: 标题: Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Recruitment: Recruiting Study Results: No Results Available Conditions: Colorectal Cancer Interventions: 药品: CS-7017|药品: Placebo URL: http://ClinicalTrials.gov/show/NCT00986440
有兴趣了解当前的临床计划是否, 研究进展, 或新兴的治疗方法可能与您的情况相关?
仅教育和研究信息. 个人医疗决定应咨询合格的医疗保健专业人员.
